HDAC-IN-63
Modify Date: 2025-09-23 12:19:05
HDAC-IN-63 structure
|
Common Name | HDAC-IN-63 | ||
|---|---|---|---|---|
| CAS Number | 2920046-95-1 | Molecular Weight | 529.42 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C25H26Cl2N6O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of HDAC-IN-63HDAC-IN-63 (Compound 63) is a dual FLT3/HDAC inhibitor (IC50: 0.844 and 30.0 nM for FLT3 and HDAC1 respectively). HDAC-IN-63 inhibits MV4-11 cell proliferation (IC50: 92 nM. HDAC-IN-63 induces apoptosis and arrests cell cycle in MV4-11 cells. HDAC-IN-63 can be used for research of acute myeloid leukemia (AML)[1]. |
| Name | HDAC-IN-63 |
|---|
| Description | HDAC-IN-63 (Compound 63) is a dual FLT3/HDAC inhibitor (IC50: 0.844 and 30.0 nM for FLT3 and HDAC1 respectively). HDAC-IN-63 inhibits MV4-11 cell proliferation (IC50: 92 nM. HDAC-IN-63 induces apoptosis and arrests cell cycle in MV4-11 cells. HDAC-IN-63 can be used for research of acute myeloid leukemia (AML)[1]. |
|---|---|
| Related Catalog | |
| Target |
0.844 and 30.0 nM for FLT3 and HDAC1[1] |
| References |
| Molecular Formula | C25H26Cl2N6O3 |
|---|---|
| Molecular Weight | 529.42 |